Validation Data Gallery
Tested Applications
| Positive WB detected in | HEK-293 cells, HeLa cells, MCF-7 cells, Rapamycin treated MCF-7 cells |
| Positive IF/ICC detected in | Rapamycin treated MCF-7 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:2000-1:10000 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
87337-2-RR targets Phospho-CAD (Ser1859) in WB, IF/ICC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Recombinant |
| Type | Antibody |
| Immunogen |
Peptide 相同性解析による交差性が予測される生物種 |
| Full Name | carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
| Calculated molecular weight | 2225 aa, 243 kDa |
| Observed molecular weight | 250 kDa |
| GenBank accession number | NM_004341 |
| Gene Symbol | CAD |
| Gene ID (NCBI) | 790 |
| Conjugate | Unconjugated |
| Form | |
| Form | Liquid |
| Purification Method | Protein A purification |
| UNIPROT ID | P27708 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol{{ptg:BufferTemp}}7.3 |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamoylase, and dihydroorotase) is a multifunctional enzyme required for the de novo synthesis of pyrimidine nucleotides. Phospho-CAD (Ser1859) refers to the phosphorylated form of the multi-enzyme CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase) on serine 1859. This modification is catalyzed by ribosomal protein S6 kinase 1 (S6K1) downstream of mTORC1 signaling and serves as a metabolic switch that converts CAD from its basal state into a highly active oligomer, thereby accelerating the first three rate-limiting steps of de novo pyrimidine synthesis. (PMID:25422319, PMID: 32974014)
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for Phospho-CAD (Ser1859) antibody 87337-2-RR | Download protocol |
| WB protocol for Phospho-CAD (Ser1859) antibody 87337-2-RR | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |



